DDC
BIIB icon

DF Dent & Co’s Biogen BIIB Stock Holding History

DF Dent & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,737
Closed -$1.8M – 183
2016
Q3 		$1.8M Sell
5,737
-82,245
-93% -$24.4M 0.05% 73
2016
Q2 		$21.3M Sell
87,982
-25,431
-22% -$6.7M 0.6% 39
2016
Q1 		$29.5M Sell
113,413
-3,316
-3% -$876K 0.86% 36
2015
Q4 		$35.8M Sell
116,729
-86,772
-43% -$24.9M 1% 35
2015
Q3 		$59.4M Buy
203,501
+56,137
+38% +$18.5M 1.68% 28
2015
Q2 		$59.5M Buy
147,364
+23,517
+19% +$9.44M 1.61% 29
2015
Q1 		$52.3M Buy
123,847
+274
+0.2% +$108K 1.29% 33
2014
Q4 		$41.9M Buy
+123,573
New +$40M 1.02% 39

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DF Dent & Co's BIIB Position: Q4 2016 in Review

DF Dent & Co sold out of Biogen (BIIB) in Q4 2016, closing a stake of 5,737 shares — an estimated $1.8M sold.

DF Dent & Co first reported a position in BIIB in Q4 2014 and held it in 8 quarters. The position peaked at $59.5M in Q2 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • DF Dent & Co reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • DF Dent & Co sold 5,737 Biogen shares in Q4 2016, an estimated $1.8M.
  • DF Dent & Co first reported a position in Biogen in Q4 2014 and held it in 8 quarters.
  • DF Dent & Co's Biogen position peaked at $59.5M in Q2 2015.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on DF Dent & Co's 13F filing for Q4 2016, filed 15 Feb 2017.